ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Gene Expression"

  • Abstract Number: 140 • 2017 Pediatric Rheumatology Symposium

    Modular Gene Expression Discrimination of Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Subphenotypes in Peripheral Blood

    Urko Marigota1, Angela Mo1, Jarod Prince2, Lai Hin Kimi Chan3, Subramaniam Kugathasan2, Greg Gibson1 and Sampath Prahalad4, 1Center for Integrative Genomics, Georgia Institute of Technology, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA, 3Pediatrics, Emory University School of Medicine, Atlanta, GA, 4Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is a heterogeneous group of diseases which have in common inflammatory arthritis, but distinct clinical and genetic associations. Using biological…
  • Abstract Number: 138 • 2017 Pediatric Rheumatology Symposium

    Modeling Transcriptional Rewiring in Neutrophils through the Course of Treated Juvenile Idiopathic Arthritis

    Zihua Hu1, Kaiyu Jiang2, Mark B. Frank3, Yanmin Chen2 and James Jarvis4, 1Center for Computational Research, University at Buffalo, Buffalo, NY, 2Pediatrics, University at Buffalo, Buffalo, NY, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Pediatrics, SUNY Buffalo School of Medicine, Buffalo, NY

    Background/Purpose: We have previously shown that neutrophils in children with polyarticular juvenile idiopathic arthritis (JIA) display abnormal transcriptional patterns linked to fundamental metabolic derangements. These…
  • Abstract Number: 1036 • 2016 ACR/ARHP Annual Meeting

    Dominant B-Cell Receptor Clones in Peripheral Blood Predict Onset of Arthritis in Individuals at Risk for Rheumatoid Arthritis

    Paul-Peter Tak1,2,3, Marieke E. Doorenspleet4, Maria de Hair5, Paul L. Klarenbeek6, Marian van Beers-Tas7, Antoine H.C. van Kampen8, Dirkjan van Schaardenburg9,10, Danielle M. Gerlag11,12, Frank Baas13 and Niek de Vries14, 1Clinical Immunology & Rheumatology F4.105, Amsterdam Rheumatology and Immunology Center, Department of Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Currently: GlaxoSmithKline, Stevenage, UK, Stevenage, United Kingdom, 3currently: Ghent University, Ghent, Belgium & Cambridge University, Cambridge, United Kingdom, 4Dept. of Clinical Immunology & Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 5Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 6Dept. of Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center | Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 7Rheumatology, Amsterdam Rheumatology & Immunology Center, Reade, Amsterdam, Netherlands, 8Dept Clin Epidemiology, Biostatistics & Bioinformatics, Academic Medical Center/Univ. of Amsterdam, Amsterdam, Netherlands, 9Clinical Immunology & Rheumatology F4.105, Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, 10Rheumatology, Amsterdam Rheumatology and immunology Center, location Reade, Amsterdam, Netherlands, Amsterdam, Netherlands, 11Clinical Immunology & Rheumatology, ARC | Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 12Current address: GSK,Clinical Unit Cambridge,R&D Projects Clinical Platforms & Sciences, Cambridge, United Kingdom, 13Department of Genome Analysis, Academic Medical Center/Univ. of Amsterdam, Amsterdam, Netherlands, 14Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: The onset of seropositive rheumatoid arthritis (RA) is preceded by the presence of specific autoantibodies in the absence of synovial inflammation. Only a subset…
  • Abstract Number: 2059 • 2016 ACR/ARHP Annual Meeting

    Serine/Arginine-Rich Splicing Factor 1 (SRSF1) Is a Novel Factor in T Cell Homeostasis and Its Selective Loss in T Cells Causes Autoimmunity and Lupus-like Nephritis

    Vaishali R. Moulton1, Hao Li2, Michael W. Mosho2, Andrew R. Gillooly2, Meghan L. Keane3 and George C. Tsokos4, 1Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Medicine/ Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Background/Purpose: T cells from patients with systemic lupus erythematosus (SLE) express reduced amounts of the critical CD3 zeta signaling chain, and produce low levels of…
  • Abstract Number: 1210 • 2016 ACR/ARHP Annual Meeting

    A Genome-Wide Association Study of Psoriatic Arthritis in Italian Population

    Mariagrazia Catanoso1, Pierluigi Macchioni1, Salvatore D'Angelo2, Antonio Marchesoni3, Roberta Ramonda4, Alberto Cauli5, Fabio Massimo Perrotta6, Roberto Bortolotti7, Guseppe Provenzano8, Giovanni Pistone9, Katya Boito10, Cristina Giuliani11, Paolo Garagnani11, Davide Gentilini12, Mariana Lofrano13, Laura Rotunno14, Mariagrazia Lorenzin15, Ignazio Olivieri13, Alessandro Mathieu16, Guido Valesini17, Giuseppe Paolazzi7, Roberto Baricchi18, Anna Maria Di Blasio12, Luigi Boiardi19, Claudio Franceschi20 and Carlo Salvarani1, 1Rheumatology Unit, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 2Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, matera, Italy, 3Rheumatology Unit, Orthopedic Institute G. Pini, Milano, Italy, 4Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy, 5University of Cagliari, Cagliari, Italy, 6Rheumatology Unit, Sapienza University, Department of Internal Medicine and Medical Specialties, Roma, Italy, 7Rheumatology Unit, Santa Chiara Hospital, Trento, Italy, 8Reumatology Unit, Villa Sofia-CTO Hospital, Palermo, Italy, 9Rheumatology Unit, ARNAS Civico, Di Cristina e Benfratelli Hospital, Palermo, Italy, 10Transfusion Medicine Unit,, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy, 11Laboratory of Molecular Anthropology, Centre for Genome Biology University, Bologna, Italy, 12Laboratory of Molecular Biology, Istituto Auxologico Italiano, IRCCS, Milano, Italy, 13Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Matera, Italy, 14Orthopedic Institute G.Pini, Rheumatology Unit, Milano, Italy, 15Department of Medicine, University of Padova - Rheumatology Unit, Padova, Italy, 16Department of Medical Sciences, Rheumatology Unit - University of Cagliari, Cagliari, Italy, 17Internal Medicine and Medical Specialties Department, Policlinico Umberto I, La Sapienza University of Rome, Roma, Italy, 18Transfusion Medicine Unit, IRCCS S. Maria Nuova Hospital, Reggio Emilia, Italy, 19Rheumatology Unit, Arcispedale S.Maria Nuova, IRCCS, Reggio Emilia, Italy, 20Laboratory of Molecular Anthropology & Centre for Genome Biology University of Bologna, Bologna, Italy

    rexm-rs12191877 (p=4.87 x10-10, OR 1.731, 95%CI =1.46-2.06), exm-rs4947248 (p=1.98 x10-9 , OR 1.56, 95%CI = 1.35-1.80). Moreover, in PsA patients we identified signals of association…
  • Abstract Number: 2064 • 2016 ACR/ARHP Annual Meeting

    Blood and Kidney Molecular Profiles Distinguish Subjects with Lupus Nephritis from Other Kidney Disorders

    Matteo Cesaroni1, Jarrat Jordan1, Marc Chevrier2, Alan Perlman3, James M. Chevalier4, Thomas Parker3, Daniel Levine3, Surya V. Seshan5, Anna Gong6, Takahiro Sato1 and Jacqueline Benson1, 1Estrela Lupus Venture, Janssen Research and Development, LLC., Spring House, PA, 2Janssen Research and Development, LLC, Collegeville, PA, 3The Rogosin Institute,New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, NY, 4Nephrology, The Rogosin Institute New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, 5Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, NY, 6The Rogosin Institute,New York Presbyterian Hospital-Weill Medical College of Cornell University, new york, NY

    Background/Purpose: Kidney biopsy remains the gold standard for diagnosis and staging of Lupus Nephritis (LN). Although kidney biopsies are commonly performed in the clinical setting,…
  • Abstract Number: 1211 • 2016 ACR/ARHP Annual Meeting

    Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants

    Matthew T. Weirauch1, Daniel Miller1, Leah C. Kottyan2, Ignacio Ibarra3, Sayeed Syed4, Xiaoting Chen1, Erin Zoller1, Arthur Lynch1, Connor Schroeder1, Josh Lee1, Albert Magnussen1, Ally Yang5, Timothy R. Hughes5, Joo-Seop Park1, Charles Vinson4 and John B. Harley6,7, 1Cincinnati Childrens Hospital, Cincinnati, OH, 2Center for Autoimmune Genomics and Etiology, Cincinnati Childrens Hospital, Cincinnati, OH, 3EMBL, Heidelberg, Germany, 4NCI, Bethesda, MD, 5University of Toronto, Toronto, ON, Canada, 6US Department of Veterans Affairs Medical Center, Cincinnati, OH, 7Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Childrens Hospital, Cincinnati, OH

    Methods: We tested the hypothesis that some autoimmune variants might act by altering the binding of the EBV-encoded transcription factor ZTA, consequently resulting in downstream…
  • Abstract Number: 2138 • 2016 ACR/ARHP Annual Meeting

    Transcriptional Analysis of Synovial Tissue Reveals Sustained Inflammatory Chemokine Expression Despite Minimal Histopathologic Change in the Destabilization of Medial Meniscus Model of Murine Knee Osteoarthritis

    Nisha Sambamurthy1,2, Vu Nguyen1,2, Jason G. Lieberthal3, George R. Dodge4,5 and Carla R. Scanzello1,2,5, 1Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2Translational Musculoskeletal Research Center, CMC Veterans Affairs Medical Center, Philadelphia, PA, 3Internal Medicine, Mount Auburn Hospital, Cambridge, MA, 4Research, CMC Veterans Affairs Medical Center, Philadelphia, PA, 5Department of Orthopedic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

    Background/Purpose: The destabilization of medial meniscus (DMM) model of instability-induced OA replicates disease-related tissue pathology (including cartilage erosion, osteophytosis) and pain-related joint dysfunction, making it…
  • Abstract Number: 1216 • 2016 ACR/ARHP Annual Meeting

    Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness

    John A. Ice1, Indra Adrianto1, Astrid Rasmussen1, Kiely Grundahl2, Michelle L. Joachims3, Graham B. Wiley1, Jennifer A. Kelly1, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Barbara M. Segal8, Nelson L. Rhodus9, Joel M. Guthridge3, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James1,16,17, Courtney G. Montgomery1, R. Hal Scofield1,17,18, Patrick Gaffney1, Kathy L. Sivils3 and Christopher J. Lessard1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 11Harvard Medical School, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 18US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disorder in which exocrine dysfunction can lead to chronic, debilitating dryness. Expression studies in SS have identified…
  • Abstract Number: 2415 • 2016 ACR/ARHP Annual Meeting

    Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (secHLH)

    Chiara Passarelli1, Manuela Pardeo2, Elisa Pisaneschi1, Antonio Novelli1, Fabrizio De Benedetti2 and Claudia Bracaglia2, 1Ospedale Pediatrico Bambino Gesù IRCCS, Unit of Medical Genetics, Laboratory of Cytogenetics and Molecular Genetics, Rome, Italy, 2Division of Rheumatology, Ospedale Pediatrico Bambino Gesù IRCCS, Roma, Italy, Rome, Italy

    Background/Purpose: Macrophage activation syndrome (MAS) is a severe complication of rheumatic disease, particularly of systemic JIA (sJIA). It is currently classified among the secondary forms…
  • Abstract Number: 68 • 2016 ACR/ARHP Annual Meeting

    Epigenetic and Expression Analysis of Ankylosing Spondylitis Association Loci Point to Key Cell Types Driving Disease

    Zhixiu Li1, Katelin Haynes2, Gethin P. Thomas3, Tony J. Kenna1, Paul Leo1 and Matthew A. Brown1, 1Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, 2University of Queensland Diamantina Institute, Brisbane, Australia, Brisbane, Australia, 3Research Office, Charles Sturt University, Wagga, Australia, Wagga, Australia

    Background/Purpose: Susceptibility to ankylosing spondylitis (AS) is primarily genetic; thus far 113 susceptibility variants for AS have been identified. However, most of the AS associated…
  • Abstract Number: 1217 • 2016 ACR/ARHP Annual Meeting

    Identification of Sjogren’s Syndrome-Associated Long Non-Coding RNAs That Are Co-Expressed with Key Protein-Coding Transcripts Involved in Dysregulated Interferon Responses

    John A. Ice1, Indra Adrianto1, Michelle L. Joachims2, Jennifer A. Kelly2, Graham B. Wiley1, Astrid Rasmussen1, Kiely Grundahl3, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Joel M. Guthridge2, Barbara M. Segal8, Nelson L. Rhodus9, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James16,17,18, Courtney G. Montgomery1, R. Hal Scofield1,18,19, Patrick Gaffney1, Kathy L. Sivils2,16 and Christopher J. Lessard1,16, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Harvard Medical School, Boston, MA, 11Massachusetts Eye and Ear Infirmary, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 18Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 19US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: The “interferon signature”, marked by transcriptional upregulation of interferon (IFN)-inducible (IFI) genes, is a common finding in Sjögren’s syndrome (SS) that is associated with…
  • Abstract Number: 2426 • 2016 ACR/ARHP Annual Meeting

    Transcriptomic Analysis of Immune Subsets in Juvenile Dermatomyositis before and after Treatment Identifies Novel Pathways Involved in Pathogenesis

    Claire Deakin1, Georg Otto2,3, Meredyth Wilkinson4, Stefanie Dowle2,3, Stefania Simou5, Lucy Marshall6, Elizabeth Rosser6, Daniel Kelberman2,3, Lucy R Wedderburn6,7,8 and Juvenile Dermatomyositis Research Group (JDRG), 1Infection, Inflammation and Rheumatology Section,, UCL Institute of Child Health, London, United Kingdom, 2Genetics & Genomic Medicine Programme, UCL Institute of Child Health, London, United Kingdom, 3National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom, 4Division of Medicine, University College London, London, United Kingdom, 5Infection, Inflammation and Rheumatology, UCL Institute of Child Health, London, United Kingdom, 6Infection, Inflammation and Rheumatology Section, UCL Institute of Child Health, London, United Kingdom, 7Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom, 8Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

    Background/Purpose:  Although proximal muscle weakness and skin rash are the typical features of juvenile dermatomyositis (JDM), little is known about disease pathogenesis, why other features…
  • Abstract Number: 77 • 2016 ACR/ARHP Annual Meeting

    Integrated Analysis of Microrna and mRNA Expression Profiles Related to Cardiovascular Disease in Monocytes from Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome Patients

    Carlos Perez-Sanchez1, Maria Ángeles Aguirre Zamorano1, Patricia Ruiz-Limon2, Nuria Barbarroja1, Yolanda Jiménez-Gómez1, Maria Carmen Abalos-Aguilera2, Ivan Arias de la Rosa2, María Galindo3, Eduardo Collantes-Estévez1, Maria Jose Cuadrado4 and Chary Lopez-Pedrera1, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, 4St Thomas Hospital, Lupus Research Unit, London, United Kingdom

    Background/Purpose: The interplay between miRNAs and their mRNA targets might constitute an important mechanism in the regulation of the proatherothrombotic status of SLE and APS…
  • Abstract Number: 1473 • 2016 ACR/ARHP Annual Meeting

    Expression of Vitamin D Receptor Associated Genes in the Aorta of Coronary Artery Disease Patients with and without Rheumatoid Arthritis

    Ingvild Oma1, Sverre Holm2,3, Jacqueline Kirsti Andersen4, Ole K. Olstad5, Ida G. Fostad6, Torstein Lyberg5, Sven Martin Almdahl7, Øyvind Molberg8 and Ivana Hollan9,10,11, 1Innlandet Hospital Trust, Lillehammer, Norway, 2Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway, 3Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, 4Norwegian University of Science and Technology, Gjøvik, Norway, 5Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway, 6Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway, 7Department of Cardiothoracic Surgery, University Hospital of North Norway, Tromsø, Norway, 8Oslo University Hospital, Oslo, Norway, 9Brigham and Women’s Hospital, Boston, MA, 10Harvard Medical School, Boston, MA, 11Lillehammer Hospital for Rheumatic Diseases, Lillahammer, Norway

    Background/Purpose: Vitamin D has an important role in the immune system, and has been linked to inflammation, rheumatoid arthritis (RA) and coronary artery disease (CAD)[1,…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 31
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology